EP1773294 - COMPOSITIONS FOR DELIVERING HIGHLY WATER SOLUBLE DRUGS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 18.10.2013 Database last updated on 24.08.2024 | Most recent event Tooltip | 18.10.2013 | Application deemed to be withdrawn | published on 20.11.2013 [2013/47] | Applicant(s) | For all designated states Adventrx Pharmaceuticals, Inc. 12390 El Camino Real Suite 150 San Diego CA 92130 / US | [2011/38] |
Former [2011/33] | For all designated states Adventrix Pharmaceuticals, Inc. 12390 El Camino Real Suite 150 San Diego CA 92130 / US | ||
Former [2011/30] | For all designated states Adventrx Pharmaceuticals, Inc. 12390 El Camino Real, Suite 150 San Diego, CA 92130 / US | ||
Former [2007/16] | For all designated states SD Pharmaceuticals, Inc. c/o Adventrx Pharmaceuticals, Inc. 6725 Mesa Ridge Road, Suite100 San Diego CA 92121 / US | Inventor(s) | 01 /
CHEN, Adrew, Xian 4646 Bryson Terrace San Diego, CA 92130 / US | [2007/16] | Representative(s) | Brasnett, Adrian Hugh Mewburn Ellis LLP City Tower 40 Basinghall Street London EC2V 5DE / GB | [N/P] |
Former [2007/16] | Brasnett, Adrian Hugh Mewburn Ellis LLP York House 23 Kingsway London WC2B 6HP / GB | Application number, filing date | 05772989.9 | 12.07.2005 | [2007/16] | WO2005US24594 | Priority number, date | US20040889226 | 12.07.2004 Original published format: US 889226 | [2007/16] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2006017246 | Date: | 16.02.2006 | Language: | EN | [2006/07] | Type: | A2 Application without search report | No.: | EP1773294 | Date: | 18.04.2007 | Language: | EN | The application published by WIPO in one of the EPO official languages on 16.02.2006 takes the place of the publication of the European patent application. | [2007/16] | Search report(s) | International search report - published on: | US | 30.03.2006 | (Supplementary) European search report - dispatched on: | EP | 23.10.2012 | Classification | IPC: | A61K9/107, A61K9/19, A61K31/475 | [2012/47] | CPC: |
A61K31/475 (EP,US);
A61K9/10 (KR);
A61K9/0019 (EP,US);
A61K9/1075 (EP,US);
A61K9/127 (KR);
A61K9/19 (EP,US);
|
Former IPC [2007/16] | A61K9/00, A61K9/127, A61K9/66, A01N25/00 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2007/16] | Extension states | AL | 01.03.2007 | BA | 01.03.2007 | HR | 01.03.2007 | MK | 01.03.2007 | YU | 01.03.2007 | Title | German: | ZUSAMMENSETZUNGEN ZUR ABGABE VON ARZNEIMITTELN MIT HOHER WASSERLÖSLICHKEIT | [2007/16] | English: | COMPOSITIONS FOR DELIVERING HIGHLY WATER SOLUBLE DRUGS | [2007/16] | French: | COMPOSITIONS POUR L'APPORT DE MEDICAMENTS HAUTEMENT SOLUBLES DANS L'EAU | [2007/16] | Entry into regional phase | 09.02.2007 | National basic fee paid | 09.02.2007 | Search fee paid | 09.02.2007 | Designation fee(s) paid | 09.02.2007 | Examination fee paid | Examination procedure | 09.02.2007 | Amendment by applicant (claims and/or description) | 09.02.2007 | Examination requested [2007/16] | 22.05.2013 | Application deemed to be withdrawn, date of legal effect [2013/47] | 17.06.2013 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2013/47] | Fees paid | Renewal fee | 27.07.2007 | Renewal fee patent year 03 | 25.07.2008 | Renewal fee patent year 04 | 28.07.2009 | Renewal fee patent year 05 | 26.07.2010 | Renewal fee patent year 06 | 12.07.2011 | Renewal fee patent year 07 | 13.07.2012 | Renewal fee patent year 08 | Penalty fee | Additional fee for renewal fee | 31.07.2013 | 09   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XY]EP0315079 (NIPPON SHINYAKU CO LTD [JP]) [X] 1,2,5,6,8,13,14,17-19 * page 2, line 42 - page 3, line 14 * * page 4, line 24 - line 32 * * page 5, line 49 - line 57 * * example 7 * * claim - * * page 4, line 37 - line 40 * [Y] 1-19; | [Y] - JUNPING WANG ET AL, "Pharmacokinetics and antitumor effects of vincristine carried by microemulsions composed of PEG-lipid, oleic acid, vitamin E and cholesterol", INTERNATIONAL JOURNAL OF PHARMACEUTICS, ELSEVIER BV, NL, (20030130), vol. 251, no. 1-2, doi:10.1016/S0378-5173(02)00580-X, ISSN 0378-5173, pages 13 - 21, XP002664476 [Y] 1-19 * paragraphs [0001] , [03.1] , [04.1] , [04.2] , [0005] * DOI: http://dx.doi.org/10.1016/S0378-5173(02)00580-X | International search | [Y]US5977172 (YOSHIKAWA HIROFUMI [JP], et al); | [Y]JP2003277281 (KUMAMOTO TECH & IND FOUND) |